Randomised controlled trial of Vinehealth® digital health cancer solutio

Not Applicable

• Conditions: Colorectal, breast and lung cancer patients commencing adjuvant systemic treatment; Cancer; Malignant neoplasm of breast, Malignant neoplasm of bronchus and lung

• Registration Number: ISRCTN44293246
• Lead Sponsor: niversity of Surrey

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-15
• Last Update Posted: 19 December 2023
• Study Completion: 2024-03-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 174

Inclusion Criteria

Patients with breast, colorectal and lung cancer who have just had surgery for their primary cancer and are about to commence adjuvant chemotherapy as part of their treatment will be approached in oncology clinics to see if they would like to participate:
1. Adults (age >18 years) commencing adjuvant cytotoxic chemotherapy at participating site for the minimum planned duration of 12 weeks
2. Breast, colorectal or lung cancer diagnosis
3. Primary disease completely excised R0 with no evidence of macroscopic residual or metastatic disease
4. Smartphone access that conforms to the following specifications:
4.1. Apple devices running iOS 9.2 (or later) or devices running Android 4.4 (or later)
4.2. Screen size of at least 4.7 inches (equivalent to an iPhone 6)
5. Able to read and write in English (Information will be provided in the Welsh language if requested for the Welsh site)
6. Able to provide informed consent

Exclusion Criteria

1. Systemic anti-cancer treatment to palliate incurable cancer for this malignancy
2. No longer undergoing systemic therapy
3. No smartphone access
4. Unable to read or write in English
5. Significant cognitive impairment

Study & Design

• Study Type: Interventional
• Study Design: Not specified